FDA clears Roche, Lilly Alzheimer's blood tests; Regenxbio gene therapy trial halted by FDA again

Reports

4

Domains carrying it

4

First reported

24 August 2026

Latest report

28 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 24 August 2026FDA clears Roche, Lilly Alzheimer's blood tests; Regenxbio gene therapy trial halted by FDA againraps.org
2. 25 August 2026Alzheimer's blood test developed by Roche, Lilly gets FDA clearanceinsideindianabusiness.com
3. 28 August 2026Roche Holding (SWX:ROP) Secures FDA Clearance For Alzheimer's Blood Testuk.finance.yahoo.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA clears new blood-based biomarker test that targets tau3 reports · 3 domains · 3 September 2026
• FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics4 reports · 4 domains · 15 August 2026
• GRAIL Bets Its Galleri Panel Will Set The FDA Bar For Future MCEDs6 reports · 6 domains · 12 August 2026
• Eli Lilly offers new weight loss drug to some patients before FDA approval3 reports · 3 domains · 7 August 2026
• Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology ...5 reports · 5 domains · 27 August 2026
• FDA approves Lytenava for wet AMD2 reports · 2 domains · 2 August 2026

◆ Share

◆ Evidence

4 reports · 4 domains

• Roche Holding (SWX:ROP) Secures FDA Clearance For Alzheimer's Blood Testuk.finance.yahoo.com · 28 August 2026
• Roche and Eli Lilly Win FDA Clearance for Alzheimer's Blood Testfinance.yahoo.com · 25 August 2026
• Alzheimer's blood test developed by Roche, Lilly gets FDA clearanceinsideindianabusiness.com · 25 August 2026
• FDA clears Roche, Lilly Alzheimer's blood tests; Regenxbio gene therapy trial halted by FDA againraps.org · 24 August 2026